Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study.
Yasuyuki ShiraishiShun KohsakaNobuhiro IkemuraTakehiro KimuraYoshinori KatsumataKojiro TanimotoMasahiro SuzukiIkuko UedaKeiichi FukudaSeiji TakatsukiPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
Among AF-HF patients, CA was associated with improved QoL and lower risk of cardiovascular events against drug therapy alone, even for patients with mildly reduced and preserved LVEF.
Keyphrases
- ejection fraction
- atrial fibrillation
- cardiovascular events
- aortic stenosis
- catheter ablation
- heart failure
- coronary artery disease
- left atrial
- cardiovascular disease
- end stage renal disease
- left atrial appendage
- clinical trial
- newly diagnosed
- left ventricular
- stem cells
- type diabetes
- acute heart failure
- randomized controlled trial
- patient reported outcomes
- mesenchymal stem cells
- aortic valve
- double blind